Cyclerion Therapeutics, Inc. - CYCN

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$309K
QoQ value delta ($000)
-$61K (-16.49%)
Implied price effect (QoQ)
+15.77%
Shares
Total shares
213,712
QoQ shares delta
-82,543 (-27.86%)
Total shares held by funds (by quarter)

Market chart (CYCN)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 17 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
GEODE CAPITAL MANAGEMENT, LLC 129 84,550 0.0%
TWO SIGMA ADVISERS, LP 35 28,300 0.0%
VANGUARD GROUP INC 29 23,490 0.0%
CITADEL ADVISORS LLC 28 18,261 0.0%
BlackRock, Inc. 26 16,797 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 24 16,137 0.0%
Kovack Advisors, Inc. 15 10,000 0.0%
VANGUARD FIDUCIARY TRUST CO 11 7,353 0.0%
FMR LLC 7 4,740 0.0%
UBS Group AG 5 3,391 0.0%
CITIGROUP INC 0 89 0.0%
MORGAN STANLEY 0 1 0.0%
GROUP ONE TRADING LLC 0 192 0.0%
MAI Capital Management 0 100 0.0%
BNP PARIBAS FINANCIAL MARKETS 0 5 0.0%
OSAIC HOLDINGS, INC. 0 130 0.0%
Activest Wealth Management 0 100 0.0%
WHI TRUST Co LLC 0 72 0.0%
Caitong International Asset Management Co., Ltd 0 4 0.0%